Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Wearable Injectors and Connected Devices Market Research Report 2022

  • RnM4429916
    • |
  • 28 April, 2022
    • |
  • Global
    • |
  • 100 Pages
    • |
  • QYResearch
    • |
  • Medical Devices & Consumables

Summary:

Industry Insights
Due to the COVID-19 pandemic, the global Wearable Injectors and Connected Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Wearable Injectors and Connected Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Wearable Injectors and Connected Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Disposable accounting for % of the Wearable Injectors and Connected Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Wearable Injectors and Connected Devices include Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, Ypsomed, Elcam Medical, Enable Injections, Unilife Corporation and West Pharma, etc. In terms of revenue, the global 3 largest players have a % market share of Wearable Injectors and Connected Devices in 2021.
This report focuses on Wearable Injectors and Connected Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Wearable Injectors and Connected Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Wearable Injectors and Connected Devices market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Disposable
Reusable
Segment by Application
Hospitals
Clinics
Home Care Settings
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Enable Injections
Unilife Corporation
West Pharma
Eitan Medical
BD Medical
Noble International
Insulet
Amgen
Roche
CeQur
ScPharmaceuticals
Frequently Asked Questions
Which product segment grabbed the largest share in the Wearable Injectors and Connected Devices market?
How is the competitive scenario of the Wearable Injectors and Connected Devices market?
Which are the key factors aiding the Wearable Injectors and Connected Devices market growth?
Which are the prominent players in the Wearable Injectors and Connected Devices market?
Which region holds the maximum share in the Wearable Injectors and Connected Devices market?
What will be the CAGR of the Wearable Injectors and Connected Devices market during the forecast period?
Which application segment emerged as the leading segment in the Wearable Injectors and Connected Devices market?
What key trends are likely to emerge in the Wearable Injectors and Connected Devices market in the coming years?
What will be the Wearable Injectors and Connected Devices market size by 2028?
Which company held the largest share in the Wearable Injectors and Connected Devices market?


Table of Contents

    1 Wearable Injectors and Connected Devices Market Overview

    • 1.1 Product Overview and Scope of Wearable Injectors and Connected Devices
    • 1.2 Wearable Injectors and Connected Devices Segment by Type
      • 1.2.1 Global Wearable Injectors and Connected Devices Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 Disposable
      • 1.2.3 Reusable
    • 1.3 Wearable Injectors and Connected Devices Segment by Application
      • 1.3.1 Global Wearable Injectors and Connected Devices Sales Comparison by Application: (2022-2028)
      • 1.3.2 Hospitals
      • 1.3.3 Clinics
      • 1.3.4 Home Care Settings
      • 1.3.5 Others
    • 1.4 Global Wearable Injectors and Connected Devices Market Size Estimates and Forecasts
      • 1.4.1 Global Wearable Injectors and Connected Devices Revenue 2017-2028
      • 1.4.2 Global Wearable Injectors and Connected Devices Sales 2017-2028
      • 1.4.3 Wearable Injectors and Connected Devices Market Size by Region: 2017 Versus 2021 Versus 2028

    2 Wearable Injectors and Connected Devices Market Competition by Manufacturers

    • 2.1 Global Wearable Injectors and Connected Devices Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Wearable Injectors and Connected Devices Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Wearable Injectors and Connected Devices Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Wearable Injectors and Connected Devices Manufacturing Sites, Area Served, Product Type
    • 2.5 Wearable Injectors and Connected Devices Market Competitive Situation and Trends
      • 2.5.1 Wearable Injectors and Connected Devices Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest Wearable Injectors and Connected Devices Players Market Share by Revenue
      • 2.5.3 Global Wearable Injectors and Connected Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 Wearable Injectors and Connected Devices Retrospective Market Scenario by Region

    • 3.1 Global Wearable Injectors and Connected Devices Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Wearable Injectors and Connected Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Wearable Injectors and Connected Devices Market Facts & Figures by Country
      • 3.3.1 North America Wearable Injectors and Connected Devices Sales by Country
      • 3.3.2 North America Wearable Injectors and Connected Devices Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe Wearable Injectors and Connected Devices Market Facts & Figures by Country
      • 3.4.1 Europe Wearable Injectors and Connected Devices Sales by Country
      • 3.4.2 Europe Wearable Injectors and Connected Devices Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Wearable Injectors and Connected Devices Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Wearable Injectors and Connected Devices Sales by Region
      • 3.5.2 Asia Pacific Wearable Injectors and Connected Devices Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America Wearable Injectors and Connected Devices Market Facts & Figures by Country
      • 3.6.1 Latin America Wearable Injectors and Connected Devices Sales by Country
      • 3.6.2 Latin America Wearable Injectors and Connected Devices Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
      • 3.6.6 Colombia
    • 3.7 Middle East and Africa Wearable Injectors and Connected Devices Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Wearable Injectors and Connected Devices Sales by Country
      • 3.7.2 Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global Wearable Injectors and Connected Devices Historic Market Analysis by Type

    • 4.1 Global Wearable Injectors and Connected Devices Sales Market Share by Type (2017-2022)
    • 4.2 Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2017-2022)
    • 4.3 Global Wearable Injectors and Connected Devices Price by Type (2017-2022)

    5 Global Wearable Injectors and Connected Devices Historic Market Analysis by Application

    • 5.1 Global Wearable Injectors and Connected Devices Sales Market Share by Application (2017-2022)
    • 5.2 Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2017-2022)
    • 5.3 Global Wearable Injectors and Connected Devices Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Gerresheimer
      • 6.1.1 Gerresheimer Corporation Information
      • 6.1.2 Gerresheimer Description and Business Overview
      • 6.1.3 Gerresheimer Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 Gerresheimer Wearable Injectors and Connected Devices Product Portfolio
      • 6.1.5 Gerresheimer Recent Developments/Updates
    • 6.2 Owen Mumford
      • 6.2.1 Owen Mumford Corporation Information
      • 6.2.2 Owen Mumford Description and Business Overview
      • 6.2.3 Owen Mumford Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 Owen Mumford Wearable Injectors and Connected Devices Product Portfolio
      • 6.2.5 Owen Mumford Recent Developments/Updates
    • 6.3 Sonceboz
      • 6.3.1 Sonceboz Corporation Information
      • 6.3.2 Sonceboz Description and Business Overview
      • 6.3.3 Sonceboz Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 Sonceboz Wearable Injectors and Connected Devices Product Portfolio
      • 6.3.5 Sonceboz Recent Developments/Updates
    • 6.4 United Therapeutics
      • 6.4.1 United Therapeutics Corporation Information
      • 6.4.2 United Therapeutics Description and Business Overview
      • 6.4.3 United Therapeutics Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 United Therapeutics Wearable Injectors and Connected Devices Product Portfolio
      • 6.4.5 United Therapeutics Recent Developments/Updates
    • 6.5 Ypsomed
      • 6.5.1 Ypsomed Corporation Information
      • 6.5.2 Ypsomed Description and Business Overview
      • 6.5.3 Ypsomed Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 Ypsomed Wearable Injectors and Connected Devices Product Portfolio
      • 6.5.5 Ypsomed Recent Developments/Updates
    • 6.6 Elcam Medical
      • 6.6.1 Elcam Medical Corporation Information
      • 6.6.2 Elcam Medical Description and Business Overview
      • 6.6.3 Elcam Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 Elcam Medical Wearable Injectors and Connected Devices Product Portfolio
      • 6.6.5 Elcam Medical Recent Developments/Updates
    • 6.7 Enable Injections
      • 6.6.1 Enable Injections Corporation Information
      • 6.6.2 Enable Injections Description and Business Overview
      • 6.6.3 Enable Injections Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Enable Injections Wearable Injectors and Connected Devices Product Portfolio
      • 6.7.5 Enable Injections Recent Developments/Updates
    • 6.8 Unilife Corporation
      • 6.8.1 Unilife Corporation Corporation Information
      • 6.8.2 Unilife Corporation Description and Business Overview
      • 6.8.3 Unilife Corporation Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.8.4 Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio
      • 6.8.5 Unilife Corporation Recent Developments/Updates
    • 6.9 West Pharma
      • 6.9.1 West Pharma Corporation Information
      • 6.9.2 West Pharma Description and Business Overview
      • 6.9.3 West Pharma Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.9.4 West Pharma Wearable Injectors and Connected Devices Product Portfolio
      • 6.9.5 West Pharma Recent Developments/Updates
    • 6.10 Eitan Medical
      • 6.10.1 Eitan Medical Corporation Information
      • 6.10.2 Eitan Medical Description and Business Overview
      • 6.10.3 Eitan Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.10.4 Eitan Medical Wearable Injectors and Connected Devices Product Portfolio
      • 6.10.5 Eitan Medical Recent Developments/Updates
    • 6.11 BD Medical
      • 6.11.1 BD Medical Corporation Information
      • 6.11.2 BD Medical Wearable Injectors and Connected Devices Description and Business Overview
      • 6.11.3 BD Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.11.4 BD Medical Wearable Injectors and Connected Devices Product Portfolio
      • 6.11.5 BD Medical Recent Developments/Updates
    • 6.12 Noble International
      • 6.12.1 Noble International Corporation Information
      • 6.12.2 Noble International Wearable Injectors and Connected Devices Description and Business Overview
      • 6.12.3 Noble International Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.12.4 Noble International Wearable Injectors and Connected Devices Product Portfolio
      • 6.12.5 Noble International Recent Developments/Updates
    • 6.13 Insulet
      • 6.13.1 Insulet Corporation Information
      • 6.13.2 Insulet Wearable Injectors and Connected Devices Description and Business Overview
      • 6.13.3 Insulet Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.13.4 Insulet Wearable Injectors and Connected Devices Product Portfolio
      • 6.13.5 Insulet Recent Developments/Updates
    • 6.14 Amgen
      • 6.14.1 Amgen Corporation Information
      • 6.14.2 Amgen Wearable Injectors and Connected Devices Description and Business Overview
      • 6.14.3 Amgen Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.14.4 Amgen Wearable Injectors and Connected Devices Product Portfolio
      • 6.14.5 Amgen Recent Developments/Updates
    • 6.15 Roche
      • 6.15.1 Roche Corporation Information
      • 6.15.2 Roche Wearable Injectors and Connected Devices Description and Business Overview
      • 6.15.3 Roche Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.15.4 Roche Wearable Injectors and Connected Devices Product Portfolio
      • 6.15.5 Roche Recent Developments/Updates
    • 6.16 CeQur
      • 6.16.1 CeQur Corporation Information
      • 6.16.2 CeQur Wearable Injectors and Connected Devices Description and Business Overview
      • 6.16.3 CeQur Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.16.4 CeQur Wearable Injectors and Connected Devices Product Portfolio
      • 6.16.5 CeQur Recent Developments/Updates
    • 6.17 ScPharmaceuticals
      • 6.17.1 ScPharmaceuticals Corporation Information
      • 6.17.2 ScPharmaceuticals Wearable Injectors and Connected Devices Description and Business Overview
      • 6.17.3 ScPharmaceuticals Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2017-2022)
      • 6.17.4 ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio
      • 6.17.5 ScPharmaceuticals Recent Developments/Updates

    7 Wearable Injectors and Connected Devices Manufacturing Cost Analysis

    • 7.1 Wearable Injectors and Connected Devices Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Wearable Injectors and Connected Devices
    • 7.4 Wearable Injectors and Connected Devices Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Wearable Injectors and Connected Devices Distributors List
    • 8.3 Wearable Injectors and Connected Devices Customers

    9 Wearable Injectors and Connected Devices Market Dynamics

    • 9.1 Wearable Injectors and Connected Devices Industry Trends
    • 9.2 Wearable Injectors and Connected Devices Market Drivers
    • 9.3 Wearable Injectors and Connected Devices Market Challenges
    • 9.4 Wearable Injectors and Connected Devices Market Restraints

    10 Global Market Forecast

    • 10.1 Wearable Injectors and Connected Devices Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Wearable Injectors and Connected Devices by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of Wearable Injectors and Connected Devices by Type (2023-2028)
    • 10.2 Wearable Injectors and Connected Devices Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Wearable Injectors and Connected Devices by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of Wearable Injectors and Connected Devices by Application (2023-2028)
    • 10.3 Wearable Injectors and Connected Devices Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Wearable Injectors and Connected Devices by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of Wearable Injectors and Connected Devices by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:
      Get latest Market Research Reports on Wearable Injectors and Connected Devices. Industry analysis & Market Report on Wearable Injectors and Connected Devices is a syndicated market report, published as Global Wearable Injectors and Connected Devices Market Research Report 2022. It is complete Research Study and Industry Analysis of Wearable Injectors and Connected Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$2,900.00
      		$5,800.00
      		2,328.70
      		4,657.40
      		2,711.50
      		5,423.00
      		449,877.00
      		899,754.00
      		241,715.00
      		483,430.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo